Chimeric antigen receptor (CAR) T cell therapy is a hot topic in healthcare. Successfully used to treat certain aggressive blood cancers for about a decade now, CAR T cell therapy is capturing the growing interest of oncologists who would like to harness its power to use against other cancer types. At Frederick National Laboratory, the Biopharmaceutical Development Program—a specialized team manufacturing experimental biotherapeutics for NCI—is at the center of an effort to develop CAR T therapies that will expand cancer treatment options, particularly for pediatric malignancies.
One of the annual rites of spring at the National Cancer Institute at Frederick returned in April, when hundreds of members of the Ft. Detrick and Frederick National Laboratory community participated in the virtual Spring Research Festival. The event was co-sponsored by the United States Army Medical Research and Development Command (USAMRDC) and the Military & Health Research Foundation (MHRF).
Look at your fingernails. What comes to mind? Now look at the veins in your arms. What about them? Odds are the words “critical” and “historic” aren’t your first thoughts, but they’d be an apt description. At NCI at Frederick and Frederick National Laboratory, nail clippings and blood specimens are two ways to make a difference in scientific research.
Mark Twain once said that the secret to getting ahead is getting started. A group of Frederick High School (FHS) students clearly took that advice to heart when they jumped at the chance to learn more about careers in science, including the Werner H. Kirsten Student Internship Program at the National Cancer Institute (NCI) at Frederick and Frederick National Laboratory (FNL).
The emergence of a virus known as monkeypox has raised many questions, most notably: Is this the new pandemic?
NCI at Frederick researchers produced 175 publications that were added to the NCI at Frederick Scientific Publications Database between January and March 2022.
The top five words found in the titles of these publications were “cell,” “disease,” “cancer,” “RNA,” and “patients.”
Spring has arrived in Frederick, and with it comes a beloved scientific tradition: the Spring Research Festival. Now in its 25th year, the festival brings together scientists, students, support staff, and spectators from across Fort Detrick, NCI at Frederick, and the larger Frederick community. Participants can expect two days of scientific excellence.
In 1972, soon after then-President Richard Nixon’s newly established Frederick Cancer Research Center hired its first employees, 24-year-old Kunio Nagashima put on a suit and tie and boarded a Boeing 747 at Tokyo’s Haneda International Airport. An electron microscopist from Kyoto University, Nagashima had a one-way ticket in his hand, bound for the United States and ready to take a new job—sight unseen.
The NCI at Frederick Scientific Publications Database added 241 publications by NCI at Frederick researchers between October 1 and December 31, 2021. In comparison, for the period between October 1 and December 31, 2020, the database added 303 publications.
They say two heads are better than one. Two detectives can close a case quicker, and twice the alarms means double the chance of making it to work on time. This is the exact logic that contractor Cooperative Research and Development Agreements (cCRADAs) embody.